Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

BB4CMU rice bran oil may help treat hair loss and gray hair.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

New hair regrowth therapies show promise but need more research.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Hair analysis could help diagnose and treat schizophrenia more effectively.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Effective PCOS treatments require targeting specific signaling pathways.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.